Total Synthesis and Structural Revision of the Alkaloid Incargranine B by Brown, Patrick D. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Synthesis and Structural Revision of the Alkaloid
Incargranine B
Citation for published version:
Brown, PD, Willis, AC, Sherburn, MS & Lawrence, AL 2013, 'Total Synthesis and Structural Revision of the
Alkaloid Incargranine B' Angewandte Chemie International Edition., 10.1002/anie.201307875
Digital Object Identifier (DOI):
10.1002/anie.201307875
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Author final version (often known as postprint)
Published In:
Angewandte Chemie International Edition
Publisher Rights Statement:
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. All rights reserved.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
 Total Synthesis and Structural Revision of the Alkaloid 
Incargranine B**† 
Patrick D. Brown,
1
 Anthony C. Willis,
1
 Michael S. Sherburn
1
 and Andrew L. Lawrence
1,
* 
 
[1]
Research School of Chemistry, Australian National University, Canberra, ACT 0200, Australia. 
[
*
]
Corresponding author; (current address) a.lawrence@ed.ac.uk, EaStCHEM, School of Chemistry, Joseph 
Black Building, University of Edinburgh, West Mains Road, Edinburgh, EH9 3JJ, UK; for crystallography e-
mail: willis@rsc.anu.edu.au 
[
**
]
We thank Prof. Zhang (School of Pharmacy, Second Military Medical University, Shanghai) for kindly 
providing copies of the processed NMR spectra. Prof. Richard J. Payne (University of Sydney) and Prof. 
Spencer J. Williams (University of Melbourne) are thanked for suggestions regarding glucosidation reactions. 
The authors thank Mr Tony Herlt (Australian National University) for assistance with HPLC separations. 
A.L.L. gratefully acknowledges financial support from the Australian Research Council in the form of a 
Discovery Early Career Researcher Award (Project ID: DE120102113).
 
[†]Dedicated to Professor Sir Jack E. Baldwin in celebration of his 75th birthday. 
Supporting information: 
Supporting information for this article is available on the WWW under http://www.angewandte.org 
Graphical abstract 
 
Keywords: 
biomimetic synthesis; domino reactions; natural products; alkaloids; structural reassignment  
This is the peer-reviewed version of the following article: 
 
Brown, P. D., Willis, A. C., Sherburn, M. S., & Lawrence, A. L. (2013). Total Synthesis and 
Structural Revision of the Alkaloid Incargranine B. Angewandte Chemie International Edition, (vol. 
iss. pp. TBC). 
 
which has been published in final form at http://dx.doi.org/10.1002/anie.201307875 
This article may be used for non-commercial purposes in accordance with Wiley Terms and 
Conditions for self-archiving (http://olabout.wiley.com/WileyCDA/Section/id-817011.html). 
 
Manuscript received: 07/09/2013; Article published: 24/10/2013 
Page 1 of 6 
Abstract 
Consideration of the likely biosynthetic origins of incargranine B, which was originally assigned an 
unprecedented indolo[1.7]napthyridine structure, led us to hypothesize that a dipyrrolo-quinoline framework 
was a more biosynthetically feasible structure. We herein demonstrate that our biosynthetically inspired 
structural revision is correct through a short biomimetic synthesis of incargranine B. 
 
Main text 
Incargranine B (1) was isolated from Incarvillea mairei var. grandiflora in 2010 by Zhang and coworkers.
[1]
 
Analysis of the obtained spectroscopic data, particularly 1D and 2D NMR data, led Zhang and co-workers to 
propose an unprecedented indolo[1.7]napthyridine structure for incargranine B (1), as shown in Scheme 1. 
This proposed structure constituted the first, and still stands as the only, reported alkaloid to contain this 
framework. 
 
 
 
Scheme 1. Our proposed biogenesis and structural revision for incargranine B (1).
[3]
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Consideration of the biosynthetic origins of incargranine B (1) led us to hypothesize that the proposed 
structure was incorrect. Incargranine B (1) formulates as a dimer that contains two glucose molecules, two 
phenylethanoid structures (C6C2) and two ornithine-derived units (C4N). Our efforts to discern a likely 
biosynthetic mechanism for a dimerization process were met with great difficulty.
[2]
 The proposed 
indolo[1.7]napthyridine core would necessitate the cleavage and formation of an unusually high number of 
bonds within any conventional biosynthesis. Although this insight does not constitute evidence against the 
proposed structure for incargranine B (1), it did lead to the development of the biosynthetic speculation 
outlined in Scheme 1. 
We considered that a phenylethanoid diamine 2 could be a biosynthetic precursor towards incargranine B (1) 
(Scheme 1).
[3]
 Thus, oxidative deamination of compound 2 and subsequent intramolecular condensation would 
result in iminium ion 3, which upon deprotonation would afford enamine 4. Iminium ion 3 and enamine 4 
could then combine through a domino Mannich/electrophilic aromatic substitution sequence, to afford a 
dipyrrolo-quinoline structure. This structure appeared to fit very well with all the spectroscopic data reported 
by Zhang for incargranine B (1).
[1]
 Therefore, we decided to embark upon a biomimetic synthesis of 
incargranine B (1) to investigate the feasibility of our biosynthetic proposal and structural revision. 
The synthesis began with DIBAL-H reduction of commercially available ethyl 4-bromobutanoate (Scheme 2). 
The resulting aldehyde was then protected as a cyclic acetal to afford alkyl bromide 5, isolated in 71% yield 
over the two steps.
[4]
 Alkyl bromide 5 was then used in a substitution reaction with commercially available 4-
aminophenethyl alcohol, using Hünig’s base and NaI. It was found that simply using an excess of 4-
aminophenethyl alcohol was sufficient to avoid di-alkylation, with mono-alkylated aniline 6 isolated in 83% 
yield. Aniline 6 was then treated with aqueous hydrochloric acid to deprotect the aldehyde and trigger the 
proposed biomimetic domino Mannich/electrophilic aromatic substitution sequence. This dimerization 
process, which forms two new C–C bonds, two new C–N bonds and three new rings in a single operation,[5] 
afforded two diastereomers 7 and 8 in a combined 50% yield.
[6]
 The relative stereochemistry of each 
diastereomer was established through single crystal X-ray analyses (Scheme 2).
[7] 
It should be noted that dimeric structures 7 and 8 were found to be unstable, particularly in solution when 
exposed to air. This instability was ascribed to autoxidation at the benzylic methine sites. Therefore, handling 
of these compounds, and derivatives thereof, in air was minimized and BHT (2,6-di-tert-butyl-4-
methylphenol) was added to stored samples. 
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Scheme 2. Synthesis of incargranine B aglycone 8.
[7] 
 
The 
1
H NMR spectrum of diastereomer 8 was strikingly similar to that reported for incargranine B (1), thus 
indicating that dimer 8 was indeed the agylcone of incargranine B (1). To definitively prove this, we needed to 
synthesize an analytical sample of the diglucoside of dimer 8. A screen of glucosyl donors and activators was 
undertaken to identify glucosidation conditions with high -selectivity, in order to avoid the production of 
unwated diastereomers. It was found that pivaloyl-protected trichloroacetimidate 9 was an effective and 
highly -selective glucosyl donor.[8] Dimer 8 was, therefore, treated with glucosyl donor 9, using TMSOTf as 
the activator to afford the two expected protected diglucoside diastereomers in 28% yield (Scheme 3).
[9]
 The 
pivaloyl groups were then removed in excellent yield using LiOH in MeOH/THF. 
Page 4 of 6 
 
Scheme 3. Double glucosidation of aglycone 8. 
 
Professor Zhang very kindly provided pdf files of the processed 1D and 2D NMR spectra for natural 
incargranine B (1). Unfortunately, Professor Zhang was unable to provide us with either the original fid files 
or an authentic sample of the natural product. Nevertheless, spectroscopic data obtained on our synthetic 1:1 
diastereomeric mixture are a close match with the available data from the natural product.
[10]
 Furthermore, the 
optical rotation for our synthetic diastereomeric mixture, []D
20
 −16.7 (c 0.275, MeOH), is in good agreement 
with that reported for natural incargranine B (1), []D
20
 −12 (c 0.275, MeOH).[1] We therefore tentatively 
conclude that the natural product also exists as a diastereomeric mixture, although conclusive proof will 
require closer scrutiny of a sample isolated from the natural source.
[11]
 It is interesting to note that a 
biosynthetically related diglucosidic alkaloid, millingtonine,
[3b] 
 also exists as a mixture of diastereomers. The 
production of these pseudo-enantiomeric diastereomers in nature is presumably due to either a late-stage 
biosynthetic glucosidation of racemic (or scalemic) aglycones,
 
or a lack of stereochemical influence exerted 
by the sugars in non-enzyme mediated biosynthetic reactions. 
In summary, consideration of the biosynthetic origins of incargranine B (1) led us to suspect that the originally 
assigned indolo[1.7]napthyridine structure was incorrect. We proposed that a dipyrrolo-quinoline framework 
was a more biosynthetically feasible structure and have now demonstrated, through total synthesis, that this 
proposed structural revision was correct.
[12]
 We submit that our rapid synthesis of incargranine B (1), which 
requires a longest linear sequence of just six steps, provides very strong evidence that a similar dimerization 
process may be occurring in nature. This work not only demonstrates the great utility of biosynthetic 
considerations in devising synthetic strategies but also in aiding the determination/reassignment of natural 
product structures. Work is ongoing in our laboratories to extend this biomimetic strategy to other related 
alkaloids.
[3]
  
Page 5 of 6 
Notes and references 
[1] Y.-H. Shen, Y.-Q. Su, J.-M. Tian, S. Lin, H.-L. Li, J. Tang, W.-D. Zhang, Helv. Chim. Acta 2010, 93, 2393–
2396. 
[2] For our previous biomimetic studies on dimeric natural products, see: a) P. D. Brown, A. C. Willis, M. S. 
Sherburn, A. L. Lawrence, Org. Lett. 2012, 14, 4537–4539; b) S. L. Drew, A. L. Lawrence, M. S. Sherburn, 
Angew. Chem. 2013, 125, 4315–4318; Angew. Chem. Int. Ed. 2013, 52, 4221–4224. 
[3] The biogenesis of incargranine A and millingtonine can also be traced back to diamine 2; see the Supporting 
Information for details. For the isolation of incargranine A, see: a) Y.-Q. Su, Y.-H. Shen, S. Lin, J. Tang, J.-M. 
Tian, X.-H. Liu, W.-D. Zhang, Helv. Chim. Acta 2009, 92, 165–170. For the isolation of millingtonine, see: b) 
T. Hase, K. Ohtani, R. Kasai, K. Yamasaki, C. Picheansoonthon, Phytochemistry 1996, 41, 317–321. 
[4] R. W. Bates, S. Sridhar, Synlett 2009, 1979–1981. 
[5] For a review of multi-bond forming processes, see: N. J. Green, M. S. Sherburn, Aust. J. Chem. 2013, 66, 267–
283. 
[6] There exists the possibility that this dimerization proceeds via a concerted cycloaddition mechanism, with 
dimers 7 and 8 the result of endo and exo-processes respectively. 
[7] CCDC 958613 (7) and CCDC 958614 (8) contain the supplementary crystallographic data for this paper. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
[8] Glucosyl donor 9 was synthesized in three steps according to the procedure of Schmidt and coworkers: P. 
Zimmermann, R. Sommer, T. Bär, R. R. Schmidt, J. Carbohydr. Chem. 1988, 7, 435–452. 
[9] [9] Analytical chiral HPLC of the deprotected diglucosides showed a 1:1 ratio of diastereomers, see the 
Supporting Information for details. 
[10] See the Supporting Information for a detailed analysis of the NMR data and a direct comparison of the 
1
H and 
13
C NMR spectra of our synthetic material with that of natural incargranine B. 
[11] At high field strength the presence of two diastereomers in our synthetic sample is evidenced by the splitting 
of peaks in the 
13
C NMR spectra. Unfortunately, the magnitude of this splitting is very small and is not visible 
on the scale of the processed NMR spectra for natural incargranine B from Professor Zhang. 
[12] For an excellent review of the role of chemical synthesis in modern structure elucidation, see: K. C. Nicolaou, 
S. A. Snyder, Angew. Chem. 2005, 117, 1036–1069; Angew. Chem. Int. Ed. 2005, 44, 1012–1044. 
